Peijia Medical saw the highest growth of 1.99% in patent filings in June and no patents were granted in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.32% and no change in grants. GlobalData’s DataBook provides a comprehensive analysis of Peijia Medical’s patent filings and grants. Buy the databook here.
Peijia Medical has been focused on protecting inventions in United States(US) with three publications in Q2 2024
The United States(US) Patent Office dominates the patent filings and grants with nearly 67% filings and 100% grants. The United States(US), and World Intellectual Property Organization(WIPO) patent Office are among the top ten patent offices where Peijia Medical is filings its patents. Among the top granted patent authorities, Peijia Medical has 100% of its grants in United States(US).
AbbVie and Wells Fargo & Co could be the strongest competitors for Peijia Medical
Cardiovascular devices related patents lead Peijia Medical portfolio
Peijia Medical has highest number of patents in cardiovascular devices. For cardiovascular devices, nearly 100% of patents were filed and 100% of patents were granted in Q2 2024.
For comprehensive analysis of Peijia Medical's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.